During the past decade, Kenneth Desantes, Md conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kenneth Desantes, Md" #1 collaborator was "Children's Oncology Group" with 1 trials as a collaborator, "EsPhALL" with 1 trials as a collaborator and "Miltenyi Biomedicine GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kenneth Desantes, Md" are "Leukemia" (1 trials), "Leukemia, Pediatric" (1 trials) and "Solid Tumors" (1 trials). Many other conditions were trialed in "Kenneth Desantes, Md" in a lesser frequency.

Most popular intervention types in "Kenneth Desantes, Md" are "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Clinimacs Cell Separation System" (1 trials), "DLI" (1 trials), "Dasatinib" (1 trials) and "conditioning chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kenneth Desantes, Md" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kenneth Desantes, Md". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kenneth Desantes, Md, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kenneth Desantes, Md, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".